CBL and myeloproliferative neoplasm: Previous studies have shown that deletions or loss-of-function mutations in CBL are frequently observed in myeloid malignancies, especially in myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes (15, 16).